Holobiome is an owner and operator of a therapeutic company intended to treat diseases of the enteric and central nervous systems.
Holobiome has raised $9.0M in total funding. The most recent round was Seed. The last funding was announced in October 2024.
Holobiome's investors include Valor Equity Partners, Astanor Ventures, iSelect Fund, Satori Capital, Alexandria LaunchLabs.
Holobiome is headquartered in Cambridge, United States.
Holobiome is an owner and operator of a therapeutic company intended to treat diseases of the enteric and central nervous systems.
Holobiome is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Holobiome — Funding & Investors." VCBacked, October 9, 2024, https://www.vcbacked.co/company/holobiome. Accessed July 19, 2026.
VCBacked. (2024). Holobiome — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/holobiome
{{cite web |title=Holobiome — Funding & Investors |url=https://www.vcbacked.co/company/holobiome |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated